Intensive sequential HD-chemotherapy is associated with the risk of severe neutropenia, thrombocytopenia and anaemia despite the use of PBSC retransplantation and haematopoetic growth factors (granulocyte colony stimulating factor) (G-CSF). This evidence concerns the gene CSF3 and Thrombocytopenia.